{"title":"Spontaneous Rupture of a Low-Grade Endometrial Stromal Sarcoma: A Case Report and Review of Imaging.","authors":"Jiali Jin, Yangyang Liu, Haiyan Cheng","doi":"10.2147/CMAR.S531483","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Endometrial stromal sarcoma (ESS) is a malignant tumor that develops from the mesenchymal tissue of the uterus. However, spontaneous rupture of ESS is uncommon. This case emphasizes the rarity of spontaneous rupture and the difficulties in preoperative diagnostic imaging, serving as a foundation for clinical diagnosis and prognosis.</p><p><strong>Case description: </strong>A 52-year-old woman presented at the clinic with right lower abdominal pain, persisting for over 5 days, significantly impacting her daily activities. Self-examination revealed a palpable abdominal mass. Ultrasonography identified an inhomogeneous echogenic mass within the uterus, initially suspected to be a uterine fibroid. Subsequent magnetic resonance imaging indicated uterine fibroids with tumor rupture and bleeding. The pathological assessment confirmed low-grade ESS. The patient underwent a total hysterectomy and double adnexectomy and is now 4 months postoperative and surviving well.</p><p><strong>Conclusion: </strong>This case highlights the significance of diagnosing spontaneous rupture of ESS and emphasizes the need for increased awareness and additional research on this uncommon condition. Our results enhance comprehension of spontaneous ESS rupture and underscore the critical need for further investigation into optimal treatment approaches.</p>","PeriodicalId":9479,"journal":{"name":"Cancer Management and Research","volume":"17 ","pages":"1555-1561"},"PeriodicalIF":2.6000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335269/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Management and Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CMAR.S531483","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Endometrial stromal sarcoma (ESS) is a malignant tumor that develops from the mesenchymal tissue of the uterus. However, spontaneous rupture of ESS is uncommon. This case emphasizes the rarity of spontaneous rupture and the difficulties in preoperative diagnostic imaging, serving as a foundation for clinical diagnosis and prognosis.
Case description: A 52-year-old woman presented at the clinic with right lower abdominal pain, persisting for over 5 days, significantly impacting her daily activities. Self-examination revealed a palpable abdominal mass. Ultrasonography identified an inhomogeneous echogenic mass within the uterus, initially suspected to be a uterine fibroid. Subsequent magnetic resonance imaging indicated uterine fibroids with tumor rupture and bleeding. The pathological assessment confirmed low-grade ESS. The patient underwent a total hysterectomy and double adnexectomy and is now 4 months postoperative and surviving well.
Conclusion: This case highlights the significance of diagnosing spontaneous rupture of ESS and emphasizes the need for increased awareness and additional research on this uncommon condition. Our results enhance comprehension of spontaneous ESS rupture and underscore the critical need for further investigation into optimal treatment approaches.
期刊介绍:
Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include:
◦Epidemiology, detection and screening
◦Cellular research and biomarkers
◦Identification of biotargets and agents with novel mechanisms of action
◦Optimal clinical use of existing anticancer agents, including combination therapies
◦Radiation and surgery
◦Palliative care
◦Patient adherence, quality of life, satisfaction
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.